- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Camurus
Market Cap: SEK 36.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 631.00
7D
2.6%
1Y
-11.2%
Bonesupport Holding
Market Cap: SEK 13.3b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 202.00
7D
-12.7%
1Y
-35.5%
Vitrolife
Market Cap: SEK 12.0b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 88.65
7D
0.6%
1Y
-38.0%